Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Out of the Blue, CFDA Makes Giant Steps Forward to Boost Drug Innovation and IP ... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on CFDA's latest move to support drug innovation, especially... (6/5/2017) China's New Cybersecurity Law And Draft Data Localization Measures Expected To Burden Multinational Companies (6/22/2017) CFDA's New Draft Policy Introduces the Chinese Version of Patent Linkage (6/15/2017) APAC Is the Fastest Growing Market for CRO Industry (6/15/2017) Alzheimer's Is China's Biggest Future Health Problem - And Biggest Healthcare Industry Opportunity (6/6/2017) ASIA: Preferred Destination for Clinical Trials (6/6/2017) Why Europe Is Resorting to China for Its Penicillin Supply (6/5/2017) Out of the Blue, CFDA Makes Giant Steps Forward to Boost Drug Innovation and IP Protection (6/5/2017) NYT: China's Ill, and Wealthy, Look Abroad for Medical Treatment (5/30/2017) Three Supreme Court Cases On Pharmaceutical Patents in China (5/25/2017) Merck's Gardasil Preps for Head-To-Head with GSK’s Cervarix in China, With Big Sales Targets Ahead (5/24/2017) For Millions of Chinese with Rare Diseases, Some Relief in Sight (5/19/2017) (free) China's FDA Aims to Speed Drug OKs with Shift To U.S.-Style Clinical Trial Application Process (5/18/2017) Winning in China's HCV Travails (5/17/2017) Big Pharma Hopes Rule Change Will Ease China Sales Pain (5/16/2017) From Imitator to Innovator (5/5/2017) Recent Executive Moves  (6/22/2017) Chi-Med Initiates a Phase I/II Clinical ...  (6/22/2017) China's Innovative Medical Withdraws fro...  (6/22/2017) Another Chinese API Producer in Data Int...  (6/22/2017) Chinese Development Zone and Pakistani U...  (6/21/2017) (free) White House Task Force Echoes Pharma Pro...  (6/21/2017) Central Government to Support More than ...  (6/21/2017) Analysis: New Product Additions of 2017 ...  (6/20/2017) Snapshot: Bayer's Urban Hospital Drug Sa...  (6/20/2017) CDE Publicizes Batch 20 of Drug Applicat...  (6/20/2017) China Establishes National Center for Ch...  (6/20/2017) Sanofi to e-Market Consumer Healthcare P...  (6/20/2017) ShangPharma Announces Second Milestone i...  (6/20/2017) (free) CFDA Announces Officially Joining the IC...  (6/19/2017) CFDA Entrusts CPIA to Solicit Comments o...  (6/16/2017) White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Fresenius Steps Up Pharma M&A with Akorn, Merck ... Global Pharmerging Market to Grow at a CAGR of 12.88% in... PhRMA Urges USTR to Protect US Innovation Abroad Analysis: New Product Additions of 2017 NRDL Snapshot of Drug Sales of Representative Hospitals in Shanghai ... Snapshot of Anti-hypertensive Drug Sales in Hospitals of Major ... QuintilesIMS: Review of Chinese Pharmaceutical Market in 2016 Sinohealth: Top 20 Western Medicines by Retail Terminal Sales China's Innovative Medical Withdraws from Investment Deal wi... Chinese Development Zone and Pakistani University Sign MOU f... Snapshot: Bayer's Urban Hospital Drug Sales Witness 10% Grow... Sanofi to e-Market Consumer Healthcare Products to the Chine... ShangPharma Announces Second Milestone in Move for Chinese S... CDE Publicizes Batch 20 of Drug Applications To Be Grant... CFDA Announces Officially Joining the ICH CFDA Entrusts CPIA to Solicit Comments on Draft Provisio... China Cracks CNY 400M Pharmaceutical Invoice Fraud Case CFDA Releases List of Reference Formulations for Generic... DSM Sinochem Wins Indian Patent Lawsuit against Sinopharm We... I-MAK Challenges Gilead's Remaining Patents of HCV Drug Sofo... China, India Named and Shamed by USTR on Lax IP PhRMA Criticizes China Over Failure to Uphold Data Exclusivi... China to Introduce Interpretations for Application of Crimin... Another Chinese API Producer in Data Integrity Mudpool a... U.S. FDA Warns Chinese API Producer for Absence of Writt... India to Make Key APIs to Reduce Dependence on China DSM Sinochem Pharmaceuticals Boosts Manufacturing Capaci... U.S. FDA Raises Concerns over Teva's Plant In China Chi-Med Initiates a Phase I/II Clinical Trial of Novel F... BeiGene Presents Phase 1 Data on BTK Inhibitor BGB-3111 ... Six Agencies Issue Joint Special 13th FYP for Healthcare... China Investigates Claims of Academic Fraud Relating to ... Chi-Med Files Chinese NDA for Anticancer Fruquintinib Central Government to Support More than 600 Healthcare I... China Establishes National Center for Children's Health Anhui Slashes BMI Payment Prices of Drug Products Number of Private Hospitals Rising But Still Insignifica... NHFPC, SATCM Issue Joint Document to Crackdown on Health... Recent Executive Moves Recent Executive Moves Recent CFDA Senior Official Moves Recent Executive Moves Recent Executive Moves Upcoming Event: Biopharma Development & Producti... Upcoming Event: 4th Annual PharmaCon Asia Upcoming Event: ISPE Conference and Exhibition 2017 Upcoming Event: International Pharma Regulatory Summit Upcoming Event: Risk Management in Clinical Practice: To... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links